Evidence suggests there is unmet demand for medication abortion and that patients highly value a choice of abortion method. Cost is a significant barrier to abortion access and can create delays in accessing early abortion care, pushing patients beyond eligibility for medication abortion. To reduce financial barriers and associated delays, reproductive health advocates have argued ...Read more >

Almost no research to date has examined the abortion needs of Asian American and Pacific Islanders (AAPIs), though existing data suggest that abortion incidence among AAPI women may be relatively high. There are likely significant opportunities to increase access to medication abortion to AAPIs, but there is evidence needed to document the knowledge of, attitudes ...Read more >

There is limited evidence supporting a highly effective medication regimen for outpatient medical abortion services at 11 and 12 weeks of gestation. Currently people seeking services at these gestational ages are generally limited to aspiration, and may need to travel farther to find a facility that provides this service. Having a reliable regimen for mifepristone-misoprostol ...Read more >

Despite significant expansion in utilization of medication abortion (MA) in the last decade, several factors, including later discovery of pregnancy, desire for privacy, and delays introduced by parental involvement (PI) requirements, may create barriers for young people ages 13 to 22 from benefiting from this expansion. As an academic-community partnership with the Colorado Organization for ...Read more >

Medication abortion holds the potential to radically expand and equalize access. However, abortion stigma has worked in numerous ways to limit access to this essential technology — undergirding over-regulation, confusing the public, and contributing to a narrative that abortion done outside the clinical setting, even with safe and effective medication, is or should be a ...Read more >

Ultrasound use in the assessment of medical abortion eligibility varies by practice site. The National Abortion Federation (NAF), the Society of Family Planning (SFP), and the World Health Organization (WHO) guidelines do not recommend the routine use of ultrasonography; however, many institutions and practices still require this as part of clinic protocol. Furthermore, many clinicians ...Read more >

We conducted a multisite, double blind, randomized clinical trial to assess the utility of nitrous oxide for pain relief in early second trimester abortion. This study randomized participants to receive either inhaled nitrous oxide or intravenous (IV) sedation with fentanyl and midazolam. We included women desiring abortion at gestational ages between 12 weeks 0 days ...Read more >

As a primary care internal medicine (IM) resident with a focus on women’s health and family planning, Dr. Tan feels passionately about the essential role of primary care in providing abortion services, especially as legal abortion access continues to be dictated by restrictive policies. Her career goal is to improve primary care medication abortion access ...Read more >

Asha Hassan is an early career Health Services Researcher and Epidemiologist. Asha completed a Bachelor of Arts Degree from the University of Wisconsin- Madison in Gender and Women’s Studies with minors in global health and African studies in 2015. After graduating she moved to Nairobi, Kenya for a year to work as a research fellow ...Read more >

Elise is a fourth year PhD student at the University of Kansas and former lobbyist, organizer, and media spokesperson for Planned Parenthood. Her research is deeply informed by her experience of working against abortion stigma in the legislative and political process. Elise currently serves as the Vice President of the Kansas Abortion Fund, where her ...Read more >